Skip to main content
Livermore
Livermore
ZHEN

Grandfield & Dodd, LLC

SEC CIK
0001308016
Latest filing
Aug 7, 2026

NVS holding history

Novartis AG in every 13F filed by Grandfield & Dodd, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVS overviewAll 13F holders of NVSFull Q2 2026 holdings

Shares (Q2 2026)
153,436
Value
$24.0M
% of portfolio
1.3%
Quarters held
22
Since Q1 2021
Holdings of NVS by Grandfield & Dodd, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026153,436$24.0M1.3%−3,470−2.2%ReducedHolders
Q1 2026156,906$24.0M1.4%+1,558+1.0%AddedHolders
Q4 2025155,348$21.4M1.2%−7,470−4.6%ReducedHolders
Q3 2025162,818$20.9M1.2%+511+0.3%AddedHolders
Q2 2025162,307$19.6M1.2%−918−0.6%ReducedHolders
Q1 2025163,225$18.2M1.1%−450−0.3%ReducedHolders
Q4 2024163,675$15.9M1.0%+1,312+0.8%AddedHolders
Q3 2024162,363$18.7M1.1%+1,821+1.1%AddedHolders
Q2 2024160,542$17.1M1.1%+778+0.5%AddedHolders
Q1 2024159,764$15.5M1.0%+1,733+1.1%AddedHolders
Q4 2023158,031$16.0M1.1%+3,005+1.9%AddedHolders
Q3 2023155,026$15.8M1.2%+1,269+0.8%AddedHolders
Q2 2023153,757$15.5M1.1%+156+0.1%AddedHolders
Q1 2023153,601$14.1M1.0%+1,538+1.0%AddedHolders
Q4 2022152,063$13.8M1.0%+12,860+9.2%AddedHolders
Q3 2022139,203$10.6M0.9%+1,734+1.3%AddedHolders
Q2 2022137,469$11.6M0.9%+3,404+2.5%AddedHolders
Q1 2022134,065$11.8M0.8%+4,480+3.5%AddedHolders
Q4 2021129,585$11.3M0.7%+3,940+3.1%AddedHolders
Q3 2021125,645$10.3M0.7%−7,294−5.5%ReducedHolders
Q2 2021132,939$12.1M0.8%+3,824+3.0%AddedHolders
Q1 2021129,115$11.0M0.8%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.